Who owns PRELUDE THERAPEUTICS INC?
- Ticker: PRLD
- CUSIP Number: 74065p101
Tip: Access positions for across all investors
Analyze quarterly positions in Prelude Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Prelude Therapeutics stock
Who bought or sold PRELUDE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 11M | $52M | 0% | Mar 2024 |
|
Baker Bros. Advisors | 10M | $48M | 0% | Mar 2024 |
|
Deerfield Management Company | 4.1M | $20M | 0% | Mar 2024 |
|
Boxer Capital | 2.6M | $12M | 0% | Mar 2024 |
|
BlackRock | 1.1M | $5.2M | 3% | Mar 2024 |
|
Vanguard Group | 1.0M | $4.8M | 1% | Mar 2024 |
|
T. Rowe Price Associates | 942k | $4.5M | -10% | Mar 2024 |
|
Massachusetts Financial Services | 508k | $2.4M | -1% | Mar 2024 |
|
Geode Capital Management | 362k | $1.7M | 9% | Mar 2024 |
|
Sio Capital Management | 320k | $1.5M | -8% | Mar 2024 |
|
Morgan Stanley | 296k | $1.4M | 21% | Mar 2024 |
|
TD Asset Management | 161k | $762k | 0% | Mar 2024 |
|
Charles Schwab Investment Management | 127k | $604k | 2% | Mar 2024 |
|
Bridgeway Capital Management | 124k | $586k | 235% | Mar 2024 |
|
Northern Trust | 122k | $579k | 6% | Mar 2024 |
|
Millennium Management | 102k | $483k | 5% | Mar 2024 |
|
Two Sigma Advisers | 70k | $333k | 14% | Mar 2024 |
|
Goldman Sachs Group | 67k | $320k | -3% | Mar 2024 |
|
Exchange Traded Concepts | 64k | $303k | 45% | Mar 2024 |
|
Two Sigma Investments | 61k | $287k | 4% | Mar 2024 |
|
Bank of New York Mellon | 40k | $190k | -21% | Mar 2024 |
|
HPM Partners | 33k | $154k | 100% | Mar 2024 |
|
Bank of America Corporation | 32k | $153k | -14% | Mar 2024 |
|
Citadel Advisors | 30k | $142k | -69% | Mar 2024 |
|
Kennedy Capital Management | 25k | $119k | 100% | Mar 2024 |
|
Hsbc Holdings | 23k | $94k | 0% | Dec 2023 |
|
Acadian Asset Management | 22k | $104k | 215% | Mar 2024 |
|
Rhumbline Advisers | 21k | $100k | 4% | Mar 2024 |
|
Barclays | 20k | $97k | -33% | Mar 2024 |
|
New York State Common Retirement Fund | 20k | $95k | 0% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 20k | $95k | 100% | Mar 2024 |
|
State of Wisconsin Investment Board | 20k | $93k | -21% | Mar 2024 |
|
Zacks Investment Management | 19k | $88k | 100% | Mar 2024 |
|
Nuveen Asset Management | 17k | $80k | 22% | Mar 2024 |
|
Jane Street | 16k | $78k | -50% | Mar 2024 |
|
Walleye Trading Advisors | 16k | $78k | 100% | Mar 2024 |
|
UBS Group | 16k | $74k | -21% | Mar 2024 |
|
Amundi | 15k | $52k | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 14k | $68k | 0% | Mar 2024 |
|
Springbok Capital Management | 14k | $66k | 100% | Mar 2024 |
|
FMR | 12k | $55k | -100% | Mar 2024 |
|
American International | 7.4k | $32k | 4% | Dec 2023 |
|
Jpmorgan Chase & Co | 6.2k | $30k | -33% | Mar 2024 |
|
Wells Fargo & Company | 5.3k | $25k | 15% | Mar 2024 |
|
Tower Research Capital | 3.3k | $16k | -4% | Mar 2024 |
|
Citigroup | 2.8k | $13k | 32% | Mar 2024 |
|
Royal Bank of Canada | 2.1k | $0 | -77% | Mar 2024 |
|
California State Teachers Retirement System | 1.5k | $7.1k | -52% | Mar 2024 |
|
Legal & General Group | 962.00 | $4.6k | 0% | Mar 2024 |
|
Summit Investment Advisors | 819.00 | $3.9k | 0% | Mar 2024 |
|
Amalgamated Bank | 334.00 | $2.0k | -61% | Mar 2024 |
|
HighMark Wealth Management | 50.00 | $237.000000 | 0% | Mar 2024 |
|
CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 1.00 | $4.000000 | 100% | Mar 2024 |
|
Who sold out of Prelude Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Woodline Partners | Sep 2023 | 200k | $618k |
Jacobs Levy Equity Management | Dec 2023 | 131k | $561k |
Squarepoint Ops | Dec 2023 | 29k | $126k |
Virtu Financial | Dec 2023 | 14k | $58k |
SG Americas Securities | Dec 2023 | 13k | $56k |
Simplex Trading | Dec 2023 | 67.00 | $0 |